Skip to main content
SpringerLink
Log in

Direct-acting antiviral-related gastrointestinal adverse drug reactions

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Xie W, et al. Direct-acting antiviral agent use and gastrointestinal safety in patients with chronic hepatitis C: a pharmacovigilance study based on FDA Adverse Event Reporting System International Journal of Clinical Pharmacy : 12 Nov 2022. Available from: URL: http://doi.org/10.1007/s11096-022-01510-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Direct-acting antiviral-related gastrointestinal adverse drug reactions. Reactions Weekly 1934, 8 (2022). https://doi.org/10.1007/s40278-022-28389-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-28389-x

Search

Navigation